Morepen Laboratories on Wednesday announced the successful subscription of its qualified institutional placement (QIP) for Rs 200 crore. The QIP is aimed at accelerating growth, enhancing institutional participation, increasing market presence, and improving its financial position. The issue was oversubscribed by 1.68 times, receiving bids totaling Rs 335 crore, which reflects the strong confidence of institutional investors. Esteemed global investors such as Bank of America Securities Europe (BOFA), Samsung India, Citigroup, Societe Generale, Nomura, BNP Paribas, Morgan Stanley, and Eminence are among those who have partnered with Morepen, setting the stage for a promising future.
Comments
Post a Comment